Home > Boards > US OTC > Miscellaneous > Therapeutic Solutions International, Inc. (TSOI)

That's been my thought, with the Patents and

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
x-ray-eyes Member Profile
 
Followed By 98
Posts 6,985
Boards Moderated 0
Alias Born 03/29/12
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/3/2020 12:43:29 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/3/2020 12:39:56 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 7/29/2020 6:08:05 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/28/2020 12:03:03 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/17/2020 5:05:03 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/17/2020 5:01:12 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 7/10/2020 10:26:14 AM
Amended Quarterly Report (10-q/a) Edgar (US Regulatory) - 7/9/2020 2:56:38 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 7/6/2020 5:16:05 PM
Therapeutic Solutions International Universal Donor Immunotherapy StemVacs™ Activates Antiviral Immune Cells InvestorsHub NewsWire - 6/30/2020 9:00:00 AM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 6/30/2020 6:23:08 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2020 2:42:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2020 2:36:40 PM
Therapeutic Solutions International Announces Intention to Use Clinical Stage NK Activating Cancer Immunotherapy InvestorsHub NewsWire - 6/22/2020 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2020 1:17:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2020 1:14:11 PM
Therapeutic Solutions International Reports Reduction of Brain Inflammation/Depression Associated Biochemical Pathway InvestorsHub NewsWire - 6/15/2020 7:06:21 AM
Therapeutic Solutions International Issues "NOT US" Notice to Shareholders InvestorsHub NewsWire - 6/14/2020 8:10:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2020 3:26:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2020 3:23:57 PM
Therapeutic Solutions International Reports QuadraMune Reduces Myeloid Suppressor Cells in 4T1 Mouse Model of Breast Cancer New InvestorsHub NewsWire - 6/11/2020 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/9/2020 1:46:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/9/2020 1:29:30 PM
Therapeutic Solutions International Initiates 500 Volunteer COVID-19 Prevention Clinical Trial Using QuadraMune™ InvestorsHub NewsWire - 6/8/2020 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2020 12:14:34 PM
x-ray-eyes   Friday, 06/26/20 10:30:35 AM
Re: Penny-Alert post# 24034
Post # of 27410 
That's been my thought, with the Patents and Trials, there may be more than 1 Bidder.

imo

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist